The Role of Endothelial Nitric Oxide Synthase Gene Polymorphism in Clinically Classified Patients with Coronary Artery Disease

Çakır, Dilek Ülker; Mete, Nuriye

doi:10.2478/v10133-010-0083-6

Cited by 1 publication

(1 citation statement)

References 39 publications

(55 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NO is a primary physiological transmitter derived from the endothelium, and plays a composite role with diverse anti-atherogenic effects as vasodilator [1]. NO is synthesised from L- arginine by means of endothelial Nitric Oxide Synthase (eNOS, type III), an isoform of Nitric Oxide Synthase (NOS) which is predominant in the walls of the blood vessels.…”

Section: Introductionmentioning

confidence: 99%

Haplotypes of NOS3 Gene Polymorphisms in Dilated Cardiomyopathy

et al. 2013

View full text Add to dashboard Cite

Dilated Cardiomyopathy (DCM) is characterized by systolic dysfunction, followed by heart failure necessitating cardiac transplantation. The genetic basis is well established by the identification of mutations in sarcomere and cytoskeleton gene/s. Modifier genes and environmental factors are also considered to play a significant role in the variable expression of the disease, hence various mechanisms are implicated and one such mechanism is oxidative stress. Nitric Oxide (NO), a primary physiological transmitter derived from endothelium seems to play a composite role with diverse anti-atherogenic effects as vasodilator. Three functional polymorphisms of endothelial nitric oxide synthase (NOS3) gene viz., T-786C of the 5′ flanking region, 27bp VNTR in intron4 and G894T of exon 7 were genotyped to identify their role in DCM. A total of 115 DCM samples and 454 controls were included. Genotyping was carried out by PCR -RFLP method. Allelic and genotypic frequencies were computed in both control & patient groups and appropriate statistical tests were employed. A significant association of TC genotype (T-786C) with an odds ratio of 1.74, (95% CI 1.14 - 2.67, p = 0.01) was observed in DCM. Likewise the GT genotypic frequency of G894T polymorphism was found to be statistically significant (OR 2.10, 95% CI 1.34–3.27, p = 0.0011), with the recessive allele T being significantly associated with DCM (OR 1.64, 95% CI 1.18 - 2.30, p = 0.003). The haplotype carrying the recessive alleles of G894T and T-786C, C4bT was found to exhibit 7 folds increased risk for DCM compared to the controls. Hence C4bT haplotype could be the risk haplotype for DCM. Our findings suggest the possible implication of NOS3 gene in the disease phenotype, wherein NOS3 may be synergistically functioning in DCM associated heart failure via the excessive production of NO in cardiomyocytes resulting in decreased myocardial contractility and systolic dysfunction, a common feature of DCM phenotype.

show abstract

Section: Introductionmentioning

confidence: 99%